- €1.78bn
- €2.29bn
- €952.17m
Brief: Fagron: NN Group Shareholding Has Crossed Disclosure Threshold Of 10%
Brief: Fagron H1 REBITDA Up At 62.9 Million Euros
Brief: Fagron Says Alychlo Completed A Private Sale Of Shares In Company
Mid-caps: Berenberg revises stocks to own in COVID-19 crisis
Fagron: Best day in over 2 years on limited COVID-19 impact
Brief: Fagron To Propose 2019 Dividend Of 0.08 Euro Per Share
Brief: Fagron FY Net Profit Up 30.3% At EUR 55.7 Million
Brief: Fagron Appoints Rob Ten Hoedt As Non-Executive Director
Wall St Week Ahead-RPT-Investors expect international stocks to outperform U.S. in 2020
Wall St Week Ahead-RPT-Investors expect international stocks to outperform U.S. in 2020
Wall St Week Ahead-Investors expect international stocks to outperform U.S. in 2020
Fagron to pay $22.5 mln to settle U.S. allegations over inflated drug prices (updated)
Brief: Fagron Says Co Reached A Final Settlement With U.S. Department Of Justice
Fagron to pay $22.5 mln to settle U.S. allegations over inflated prices
Brief: Fagron Reports Norges Bank Shareholding Beyond Disclosure Threshold Of 3%
Brief: Fagron Increases Share Capital Through Warrant Exercises to EUR 496.5 Mln
French and Benelux stocks-Factors to watch
Brief: Waterland And Baltisse Announces Private Placement Of Around 9.3 Million Shares In Fagron
Fagron: shares rise on Q3 beat, growth prospects